Connor, Clark & Lunn Investment Management (CC&L)’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,038
Closed -$248K 1445
2024
Q1
$248K Sell
14,038
-42,303
-75% -$670K ﹤0.01% 1334
2023
Q4
$873K Sell
56,341
-21,068
-27% -$275K ﹤0.01% 896
2023
Q3
$1.06M Buy
77,409
+57,348
+286% +$844K 0.01% 798
2023
Q2
$346K Buy
+20,061
New +$410K ﹤0.01% 1079
2021
Q1
Sell
-12,524
Closed -$550K 1001
2020
Q4
$550K Buy
12,524
+1,844
+17% +$87.8K ﹤0.01% 713
2020
Q3
$506K Buy
+10,680
New +$433K ﹤0.01% 725

Other funds holding CYRX

Connor, Clark & Lunn Investment Management (CC&L)'s CYRX Position: Q2 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of CryoPort (CYRX) in Q2 2024, closing a stake of 14,038 shares — an estimated $248K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CYRX in Q3 2020 and held it in 6 quarters. The position peaked at $1.06M in Q3 2023. 160 funds tracked by Wall St. Rank hold CYRX as of Q2 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining CryoPort position as of Q2 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 14,038 CryoPort shares in Q2 2024, an estimated $248K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CryoPort in Q3 2020 and held it in 6 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s CryoPort position peaked at $1.06M in Q3 2023.
  • 160 funds tracked by Wall St. Rank held CryoPort as of Q2 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2024, filed 9 Aug 2024.